Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NA
This clinical trial studies fludarabine phosphate, low-dose total body irra...
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
PHASE4
This is an efficacy and safety study to compare aprepitant with ondansetron...
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
PHASE2
RATIONALE: Drugs used in chemotherapy, such as melphalan, leucovorin, oxali...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer
N/A
This single arm study aims to evaluate the rate of conversion therapy in pa...
Status
Unknown
Location
Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
PHASE2
This phase II trial evaluates whether early switching from modified fluorou...